May 5, 2020 / 9:28 PM / 25 days ago

BRIEF-Deciphera Pharmaceuticals Announces First Quarter 2020 Financial Results

May 5 (Reuters) - Deciphera Pharmaceuticals Inc:

* DECIPHERA PHARMACEUTICALS, INC. ANNOUNCES FIRST QUARTER 2020 FINANCIAL RESULTS

* Q1 LOSS PER SHARE $1.36

* Q1 EARNINGS PER SHARE ESTIMATE $-1.26 — REFINITIV IBES DATA

* NDA FOR RIPRETINIB FOR TREATMENT OF ADVANCED GIST UNDER REVIEW BY U.S. FDA WITH PDUFA DATE OF AUGUST 13, 2020

* Q1 2020 ENDED WITH CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $691.5 MILLION

* CASH RUNWAY EXPECTED INTO SECOND HALF OF 2022 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below